Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Not one disease: asthma types and the drugs that target them

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Asthma behaves like one disease at the inhaler level and like several at the severe end. The differences matter most for people whose asthma is not controlled despite good treatment.

For them, a blood test and a breath test now determine which of several antibody treatments is likely to work, and the results have been substantial.

Related pages: Asthma

The bottom line

What we know
  • Asthma is divided broadly into type 2 high and type 2 low inflammation.
  • Type 2 high asthma usually responds well to inhaled corticosteroids.
  • Type 2 low asthma is less steroid-responsive and harder to treat.
  • Biologic antibody treatments target specific pathways in severe asthma.
What is still open
  • How to treat type 2 low asthma, where options remain limited.
  • Whether biologics can modify the long-term course of the disease rather than control it.

The story, step by step

  1. 1. Allergic asthma ()
  2. 2. Eosinophilic asthma ()
  3. 3. Type 2 low asthma ()
  4. 4. Exercise-induced ()
  5. 5. Biologics ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

The common one

Review of many studies

What happens

The most frequent pattern, and the one most people picture.

What the research shows

  • Usually begins in childhood, often alongside eczema, hay fever or food allergy, and often with a family history of allergy.
  • Driven by IgE antibodies against specific allergens: house dust mite, pollens, pets, mould.
  • Markers include raised total and allergen-specific IgE, raised blood eosinophils, and raised exhaled nitric oxide.
  • It responds well to inhaled corticosteroids, which is a large part of why those drugs work so well for most people.
  • This is type 2 high inflammation, named after the type 2 immune response involved.

Why it matters

If asthma started in childhood alongside hay fever or eczema, this is almost certainly the pattern, and standard treatment usually works.

What's still uncertain

  • Allergen avoidance measures have less evidence behind them than the allergy itself would suggest.

Read more

Next: Eosinophilic asthma

Part 2 of 5

Adult-onset, and harder

Review of many studies

What happens

A type 2 high pattern without the allergic trigger, and a frequent cause of severe asthma.

What the research shows

  • Often begins in adulthood, sometimes in people with no history of allergy at all.
  • Driven by eosinophils recruited through interleukin-5, often by innate immune cells rather than by allergen-specific antibodies.
  • Blood eosinophil counts are high and exhaled nitric oxide is often raised.
  • It is frequently associated with chronic sinus disease and nasal polyps, and with aspirin-exacerbated respiratory disease, where aspirin and other anti-inflammatories trigger severe reactions.
  • It is often more severe and less responsive to standard-dose inhaled steroids than allergic asthma, and it is the group where anti-IL-5 biologics work best.

Why it matters

Adult-onset asthma with nasal polyps and a reaction to aspirin is a recognizable pattern worth naming to a clinician, because it changes the treatment options.

What's still uncertain

  • Blood eosinophil counts fluctuate and are suppressed by oral steroids, which complicates testing.

Read more

Next: Type 2 low asthma

Part 3 of 5

The difficult group

Review of many studies

What happens

Asthma without eosinophilic inflammation, and the area where treatment options are thinnest.

What the research shows

  • Normal eosinophil counts and normal exhaled nitric oxide. Sputum shows neutrophils or few inflammatory cells at all.
  • Associated with adult onset, obesity, smoking, occupational exposures and recurrent respiratory infections.
  • It responds less well to corticosteroids, which is important because the usual response to poor control is to increase the steroid dose.
  • Weight management has reasonable evidence in obesity-associated asthma, and it is one of the few interventions that works in this group.
  • Long-term low-dose azithromycin has evidence as an add-on in some people with persistent uncontrolled asthma, and it is specialist-directed because of effects on heart rhythm, hearing and antibiotic resistance.

Why it matters

If steroids keep being increased without benefit, the type of inflammation is worth testing rather than assuming more of the same will work.

What's still uncertain

  • Type 2 low asthma is less well understood and has no targeted biologic treatment.

Read more

Next: Exercise-induced

Part 4 of 5

Common, and usually manageable

Review of many studies

What happens

Narrowing triggered by exertion, which affects many people with asthma and some without.

What the research shows

  • Symptoms typically begin five to fifteen minutes after vigorous exercise rather than during it, and settle within an hour.
  • The mechanism is drying and cooling of the airway as large volumes of air pass through, which triggers mast cells to release their mediators.
  • Cold, dry air makes it much worse, which is why it is prominent in winter sports and in swimming less so.
  • Prevention is usually a reliever or ICS-formoterol before exercise, plus a proper warm-up and, in cold weather, breathing through a scarf or mask.
  • Frequent exercise-induced symptoms in someone on treatment usually means the underlying asthma is not well controlled rather than that exercise should be avoided.

Why it matters

Exercise-induced symptoms are a reason to review treatment, not a reason to stop exercising. Well-controlled asthma should allow full activity.

What's still uncertain

  • Exercise-induced bronchoconstriction also occurs in people without asthma, particularly athletes.

Read more

Next: Biologics

Part 5 of 5

What changed for severe asthma

Review of many studies

What happens

For people whose asthma stays uncontrolled on high-dose inhalers, antibody treatments now exist and they have changed outcomes substantially.

What the research shows

  • Omalizumab blocks IgE, for allergic asthma.
  • Mepolizumab, reslizumab and benralizumab target interleukin-5 or its receptor, for eosinophilic asthma.
  • Dupilumab blocks the interleukin-4 receptor, affecting both IL-4 and IL-13, and also treats eczema and nasal polyps.
  • Tezepelumab blocks TSLP, an alarm signal released by the airway lining, and is the one option with benefit across inflammatory types including some type 2 low asthma.
  • They are specialist-prescribed, given by injection, and chosen by phenotype using eosinophil counts, FeNO and IgE. The aim is to avoid long-term oral steroids, whose cumulative harms include osteoporosis, diabetes, cataracts, adrenal suppression and weight gain.

Why it matters

If asthma remains uncontrolled on high-dose inhalers, referral for phenotyping is the next step rather than another dose increase.

What's still uncertain

  • Biologics are expensive, access varies, and not everyone responds.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.